The Open University
Gamma Delta T cell Responses to Diverse Diseases: Tuberculosis, Cancer and COVID-19
Abstract
dc:description.abstractγδ T cells are unconventional cells involved in innate and adaptive immunity. They are able to respond rapidly and have roles in a range of diseases. The tuberculosis (TB) vaccine, BCG, can activate a γδ T cell subset (Vγ9Vδ2) through MHC-independent mechanisms. BCG can induce ‘off-target’ protection against non-mycobacterial infections, including respiratory viruses, and is used as a treatment for some malignancies. In this thesis, γδ T cell responses are characterised in the macaque model in the context of diverse diseases: TB, COVID-19 and tumour, and the impact of BCG vaccination upon responses assessed. <br></br><br></br> γδ T cells were characterised in macaque subspecies with differing susceptibilities to TB. Differences in basal-level frequency and mycobacteria-responsive phenotypes and cytotoxicity were associated with divergent TB resilience between species. The γδ T cell profile was explored following BCG vaccination delivered by different routes and Vδ2 cells were found to be associated with the enhanced TB protection imparted by intravenous (IV) vaccination. The frequency of inflammatory cytokine producing Vδ2 cells at lung mucosal surfaces were greater following IV BCG, and were able to be induced in animals that received ID vaccination followed by aerosol delivered BCG revaccination. <br></br><br></br> In a macaque SARS-CoV-2 challenge model, γδ T cells rapidly expressed activation markers and left the vascular circulation. Prior aerosol BCG vaccination altered the SARS-CoV-2-induced immune response, but did not result in superior protection. Lastly, <i>in vitro</i> expansion techniques were optimised for macaque Vδ2 cells and used to undertake tumour killing assays. These indicated greater tumoricidal activity in Vδ2 cells from IV BCG vaccinated macaques relative to cells from the same animals prior to vaccination. <br></br><br></br> Results presented in this thesis support the use of BCG to enhance γδ T cell activity against diverse diseases, and indicate mechanisms and functional characteristics that could be utilised to enable better therapeutic outcomes.
Degree
thesis:*- Name dc:type.qualificationname
- phd
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- The Open University
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Morrison, Alexandra
Rights
- Language dc:language
- en